On the contrary, Klhl14-AS and PAR5 are severely downregulated both in benign and small cancer lesions, while in large cancer lesions, their levels are rescued, suggesting that they could play a tumor suppressor role specifically in early phases of disease progression. Here, PWAR5 is linked to neoplasm.